Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

761
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

628
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
628
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Tertiary Healthcare System01:21

Tertiary Healthcare System

2.4K
Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide association mapping and haplotype analysis reveal the genetic architecture of sodicity tolerance in bread wheat (Triticum aestivum L.).

Scientific reports·2026
Same author

Does active case finding detect TB early in programme settings? A national-level study in India.

Public health action·2026
Same author

Global status of policies and practices for systematic TB screening in high-burden countries.

IJTLD open·2025
Same author

Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013-2020.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Mortality estimates of central nervous system TB in India.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Pathways to diagnosis of pediatric TB patients: A mixed methods study from India.

The Indian journal of tuberculosis·2021

Related Experiment Video

Updated: Mar 24, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K

Public-private mix for TB care in India: Concept, evolution, progress.

Neeraj Kulshrestha1, Sreenivas Achuthan Nair2, K Rade3

  • 1Central TB Division, Directorate of Health Services, Ministry of Health and Family Welfare, New Delhi, India.

The Indian Journal of Tuberculosis
|March 13, 2016
PubMed
Summary

The Revised National Tuberculosis Control Programme (RNTCP) in India engages private partners to expand tuberculosis (TB) care access. This public-private mix strategy aims to reach all patients with essential TB services.

Keywords:
IndiaPartnershipPublic–private mixRevised National Tuberculosis Control ProgrammeTuberculosis

More Related Videos

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.5K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.2K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.5K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.2K

Area of Science:

  • Public health
  • Infectious disease control
  • Healthcare policy

Background:

  • Achieving universal access to tuberculosis (TB) care and treatment is a global health priority.
  • The Revised National Tuberculosis Control Programme (RNTCP) in India seeks to reach underserved populations.
  • Engaging diverse stakeholders is crucial for effective TB control.

Purpose of the Study:

  • To detail the concept of the public-private mix for TB care within the RNTCP.
  • To describe the evolution and progress of this strategy over decades in India.
  • To highlight innovative partnership mechanisms for TB notification.

Main Methods:

  • Synergizing efforts of all partners and stakeholders.
  • Engaging with private sector partners in major Indian cities.
  • Implementing innovative partnership mechanisms for TB notification.

Main Results:

  • The RNTCP has actively engaged the private sector to enhance TB care delivery.
  • Innovative partnerships have been developed to improve TB case notification.
  • Progress has been made in expanding TB services through collaborative efforts.

Conclusions:

  • The public-private mix model is a key strategy for achieving universal TB care access in India.
  • Continued synergy between public and private sectors is essential for TB control.
  • The RNTCP's approach demonstrates a scalable model for integrating private healthcare providers.